相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patients
Paul C. Guest et al.
BIOMARKERS IN MEDICINE (2014)
Biomarkers in psychosis: an approach to early identification and individualized treatment
Heline Mirzakhanian et al.
BIOMARKERS IN MEDICINE (2014)
Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia
Brett A. English et al.
BIOMARKERS IN MEDICINE (2014)
Precompetitive consortium approach to validation of the next generation of biomarkers in schizophrenia
Colin T. Dourish et al.
BIOMARKERS IN MEDICINE (2014)
Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses
Veronica B. Perez et al.
BIOMARKERS IN MEDICINE (2014)
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
Paul Morgan et al.
DRUG DISCOVERY TODAY (2012)
Current insights into the pathophysiology of Alzheimer's disease: selecting targets for early therapeutic intervention
Harald Hampel
INTERNATIONAL PSYCHOGERIATRICS (2012)
Identification of a biological signature for schizophrenia in serum
E. Schwarz et al.
MOLECULAR PSYCHIATRY (2012)
Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?
S. Kapur et al.
MOLECULAR PSYCHIATRY (2012)
Validation of experimental medicine methods in psychiatry: The P1 vital approach and experience
Gerard R. Dawson et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Challenges in the development of companion diagnostics for neuropsychiatric disorders
Tania Nikolcheva et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Special issue on CNS experimental medicine
Gerard R. Dawson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Research in people with psychosis risk syndrome: a review of the current evidence and future directions
Christoph U. Correll et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2010)
Integrating ADNI results into Alzheimer's disease drug development programs
Jeffrey L. Cummings
NEUROBIOLOGY OF AGING (2010)